Exelixis Overview
Exelixis Target Price
See Exelixis's analyst price targets ($52) vs the current share price.
Get informed when a big investor buys or sells
+ FollowShare Price
$56.12
Average Target Price
$52.00
7.3% downside
7.3% downside11 analysts in the last 4 months
High: $56 | Low: $46
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-08-18 | BMO Capital | $54 | 3.8% downside |  |
| 2026-08-06 | Leerink PartnersAndrew Berens | $52 | 7.3% downside | |
| 2026-08-06 | Truist FinancialGregory Renza | $52 | 7.3% downside | |
| 2026-08-03 | UBS | $55 | 2% downside | |
| 2026-07-23 | Morgan StanleySean Laaman | $53 | 5.6% downside | |
| 2026-07-14 | BarclaysEtzer Darout | $49 | 12.7% downside | |
| 2026-07-13 | Wells Fargo | $49 | 12.7% downside | |
| 2026-07-07 | RBC Capital | $46 | 18% downside | |
| 2026-07-02 | UBSAshwani Verma | $52 | 7.3% downside | |
| 2026-07-02 | H.C. WainwrightRobert Burns | $56 | 0.2% downside | |
| 2026-06-25 | Truist FinancialGregory Renza | $54 | 3.8% downside | |
| 2026-04-20 | Barclays | $45 | 19.8% downside | |
| 2026-02-12 | H.C. Wainwright | $54 | 3.8% downside | |
| 2026-02-11 | Stifel Nicolaus | $44 | 21.6% downside | |
| 2026-02-04 | BarclaysEtzer Darout | $44 | 21.6% downside | |
| 2026-02-02 | Morgan StanleySean Laaman | $49 | 12.7% downside | |
| 2026-01-14 | Truist Financial | $51 | 9.1% downside | |
| 2026-01-08 | H.C. WainwrightRobert Burns | $52 | 7.3% downside | |
| 2026-01-08 | Morgan Stanley | $48 | 14.5% downside | |
| 2026-01-05 | UBS | $41 | 26.9% downside | |
| 2025-11-05 | H.C. WainwrightRobert Burns | $49 | 12.7% downside | |
| 2025-11-05 | Stifel NicolausStephen Willey | $43 | 23.4% downside | |
| 2025-11-05 | BarclaysEtzer Darout | $41 | 26.9% downside | |
| 2025-11-05 | OppenheimerSilvan Tuerkcan | $36 | 35.9% downside | |
| 2025-10-21 | Morgan Stanley | $44 | 21.6% downside | |
| 2025-10-21 | Leerink Partners | $48 | 14.5% downside | |
| 2025-10-21 | Wells FargoDerek Archila | $30 | 46.5% downside | |
| 2025-09-17 | Morgan Stanley | $50 | 10.9% downside | |
| 2025-09-17 | Goldman Sachs | $47 | 16.3% downside | |
| 2025-09-16 | Barclays | $40 | 28.7% downside | |
| 2025-08-12 | H.C. WainwrightRobert Burns | $46 | 18% downside | |
| 2025-07-30 | UBS | $38 | 32.3% downside | |
| 2025-07-15 | Truist FinancialAsthika Goonewardene | $56 | 0.2% downside | |
| 2025-07-11 | UBSAshwani Verma | $43 | 23.4% downside | |
| 2025-06-24 | Jefferies | $50 | 10.9% downside | |
| 2025-05-15 | GuggenheimMichael Schmidt | $45 | 19.8% downside | |
| 2025-05-14 | Morgan StanleySean Laaman | $47 | 16.3% downside | |
| 2025-03-13 | RBC Capital | $40 | 28.7% downside | |
| 2025-01-27 | JMP SecuritiesSilvan Tuerkcan | $41 | 26.9% downside | |
| 2025-01-10 | H.C. WainwrightRobert Burns | $40 | 28.7% downside | |
| 2025-01-07 | GuggenheimMichael Schmidt | $42 | 25.2% downside | |
| 2024-10-30 | BMO CapitalEtzer Darout | $36 | 35.9% downside | |
| 2024-10-30 | Truist FinancialAsthika Goonewardene | $38 | 32.3% downside | |
| 2024-10-30 | Piper SandlerJoseph Catanzaro | $36 | 35.9% downside | |
| 2024-10-30 | CitigroupDavid Lebowitz | $38 | 32.3% downside | |
| 2024-10-16 | Leerink PartnersChristopher Liu | $28.5 | 49.2% downside | |
| 2024-10-16 | RBC CapitalKennen MacKay | $34 | 39.4% downside | |
| 2024-10-16 | Goldman SachsChris Shibutani | $18 | 67.9% downside | |
| 2024-10-15 | JefferiesAkash Tewari | $33 | 41.2% downside | |
| 2024-10-15 | Morgan StanleyJeffrey Hung | $30 | 46.5% downside | |